SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – FATE
- Monday, February 13, 2023, 7:13
- PR Newswire
- Add a comment
NEW YORK, Feb. 13, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against certain officers and directors of Fate Therapeutics, Inc. (“Fate” or the “Company”) (NASDAQ: FATE). The class action, filed in the United States District Court for the…
About the Author
admin has written 21721 stories on this site.